AMANDA ERA: Open Payments
NPI 1649495250 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 7 payments from 5 companies in 2025. Trend: 2023 $175 · 2024 $256 · 2025 $323
Food & beverage: $269Education: $54
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $199 |
| Janssen Biotech, Inc. | 1 | $54 |
| ABBVIE INC. | 2 | $37 |
| Stryker Corporation | 1 | $18 |
| PFIZER INC. | 1 | $15 |
Products named: REZDIFFRA, TREMFYA, SKYRIZI, NEPTUNE, XELJANZ, RINVOQ.
Industry payments across MD — which companies pay providers there.
